Alexis Weston

Alexis Weston has built a robust career in the biotechnology and research sectors, currently serving as Head of Business Development & Project Management at Stingray Therapeutics since January 2020 and as Director of Strategic Development at Black Canyon Bio beginning January 2024. Prior experience includes a role as Research Associate III and Lab Manager at the Translational Genomics Research Institute (TGen) since February 2018, as well as multiple positions at Huntsman Cancer Institute from September 2014 to February 2018, culminating in the role of Sr. Lab Specialist - Lab Manager. Alexis Weston holds a Bachelor of Science degree in Chemistry/Biology from Westminster University, attained in 2014.